Rapid weight loss, which can occur with the use of semaglutide, especially at higher doses for obesity treatment, has long been recognized as a risk factor for gallstone formation
The meds are prescribed to people with obesity and/or Type 2 diabetes
MANAGEMENT OF HYPOGLYCEMIA 11
That means the study met its main goal, but those watching the weight-loss drug race closely had pegged their hopes on an average result for CagriSema of at least 25% weight loss, which would set a new bar for a field thats already been revolutionized by GLP-1 drugs
By improving both energy availability and energy precision, GLP-1s help stabilize neuronal metabolism, reduce oxidative stress, and create conditions more conducive to synaptic maintenance and plasticity
Perhaps you can go for a walk during lunchtime